Loading the section…
The price of Novartis AG (NVS) on October 9, 2026 is 143.75 USD, +0.45% on the day. Over 52 weeks the stock traded between 121.57 USD and 170.46 USD; the price now sits 45% of the way up that range. Over the past year the price changed by +8.65%.
Closing prices for 9 October 2026
Next earnings report: 27 October 2026, before market open · Earnings calendar
Change over the period shown (line colour): +11.33 %
Novartis AG trades on NYSE under the ticker NVS. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks NVS has traded between 121.57 $ and 170.46 $. As of 9 October 2026 the price stood 45.37 % of the way from the 52-week low to the high.
Over one year NVS shares rose 8.65 %; over six months they fell 6.69 %. Volatility over 90 days is 35.49 %. Dividends are not included: this is price change only, as of 9 October 2026.
Novartis AG reported revenue of 54.5B $ and net income of 14.0B $ for the latest fiscal year. Net margin is 25.61 %. Revenue changed by +8.38 % year over year. Earnings per share are 7.15 $.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 142.92 | 143.96 | 142.80 | 143.75 | 2M |
| 8 October 2026 | 142.77 | 143.29 | 140.68 | 143.11 | 2M |
| 7 October 2026 | 143.12 | 144.28 | 142.55 | 143.28 | 2M |
| 6 October 2026 | 141.32 | 141.39 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Novartis AG (NVS) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 54.5bn $, net income was 14.0bn $. Incorporated in CH.
This summary is compiled automatically from SEC filings and exchange data.
Address:LICHTSTRASSE 35, BASEL, CH 4056, CH
NVS has a return on equity of 30.00 %, above the sector median of −41.68 %. Return on assets is 12.59 %, above the sector median of −32.11 %. Operating margin is 32.36 %, above the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 139.67 |
| 140.79 |
| 2M |
| 5 October 2026 | 141.02 | 141.02 | 139.31 | 140.93 | 1M |
| 2 October 2026 | 141.46 | 141.57 | 139.95 | 141.00 | 2M |
| 1 October 2026 | 142.22 | 142.50 | 140.87 | 141.05 | 2M |
| 30 September 2026 | 145.39 | 145.50 | 142.56 | 142.57 | 3M |
| 29 September 2026 | 144.81 | 146.18 | 144.46 | 145.71 | 2M |
| 28 September 2026 | 145.77 | 147.03 | 145.72 | 146.88 | 2M |
| 25 September 2026 | 144.57 | 145.51 | 144.00 | 145.46 | 1M |
| 24 September 2026 | 143.00 | 144.66 | 142.91 | 143.57 | 2M |
| 23 September 2026 | 143.15 | 143.94 | 142.03 | 142.71 | 3M |
| 22 September 2026 | 141.26 | 141.80 | 140.00 | 141.28 | 2M |
| 21 September 2026 | 141.96 | 142.18 | 140.96 | 140.98 | 2M |
| 18 September 2026 | 140.87 | 141.15 | 139.60 | 140.37 | 2M |
| 17 September 2026 | 140.12 | 141.21 | 139.97 | 140.92 | 2M |
| 16 September 2026 | 140.58 | 141.46 | 138.28 | 138.70 | 2M |
| 15 September 2026 | 138.76 | 139.11 | 137.37 | 138.62 | 2M |
| 14 September 2026 | 141.64 | 141.64 | 138.99 | 138.99 | 2M |